CMS Open Payments · Program Year 2024
Masimo Corporation
Masimo Corporation reported $4,020,182.40 across General Payments, Research, and Ownership to 2,386 physicians and teaching hospitals across 2,766 transactions.
- $4.0M
- All-tracks total
- 2,766
- Transactions
- 2,386
- Recipients
- +$583.0K
- General Payments vs PY2023
Masimo Corporation reported $4,020,182.40 across all CMS Open Payments tracks (General + Research + Ownership) to 2,386 physicians and teaching hospitals in Program Year 2024 - ranking #307 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,607,386.10, averaging $1.7K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer masimo-corporation Masimo Corporation
$4.0M · #307/1,925 · 0.0% industry · PY2024
- TOT $4.0M
- RANK #307
- SHARE 0.0%
- TXN 2,766
- RCP 2,386
- CAT 7
- GEN $2.6M
- ΔGEN +$583.0K
- TOP1 50.8%
- PY 2024
Volume peers
Nearest volume peer: ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($4.0M)
Masimo Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Masimo Corporation's CMS-reported General Payments increased by $583.0K (+28.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MASIMO CORPORATIONPY2023: MASIMO CORPORATIONPY2024: Masimo Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $2,024,349.65
- PY2024
- $2,607,386.10
What the Data Shows for Masimo Corporation
Rank #307 of 1,925 companies in CMS Open Payments for 2024 belongs to Masimo Corporation, which reported $4,020,182.40 across 2,766 transactions to 2,386 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $1.5K per transaction and $1.7K per recipient.
Of the 7 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $1.8M across 177 transactions, 70.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Masimo Corporation's 7-category general-payment breakdown at $1.8M, 70.9% of the reported total.
Masimo Corporation reports 7 general-payment categories - the top three are Compensation for Services Other Than Consulting (70.9%), Consulting Fee (11.7%), and Long-Term Medical Supply or Device Loan (11.0%). The remaining 4 categories make up 6.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Masimo Corporation divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $1.8M | 177 | 70.9% |
| Consulting Fee | $305.5K | 27 | 11.7% |
| Long-Term Medical Supply or Device Loan | $287.4K | 782 | 11.0% |
| Royalty or License | $116.9K | 5 | 4.5% |
| Food and Beverage | $33.9K | 1,388 | 1.3% |
| Space Rental or Facility Fees | $13.3K | 2 | 0.5% |
| Travel and Lodging | $1.8K | 5 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,971,596.41 (75.6%) of $2,607,386.10 in this company's General Payments records across 1,125 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Masimo Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Mary Hitchcock Memorial Hosp
$1,324,418.00 across 13 reported transactions
- 2
Rajesh Panjabi
$180,000.00 across 12 reported transactions
- 3
Foead Geula
$161,934.33 across 55 reported transactions
- 4
Shveta Jain
$160,376.56 across 65 reported transactions
- 5
Edward Lizano
$144,867.52 across 45 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Masimo Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Masimo Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Masimo Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Impulse Dynamics (USA) Inc.
Intellijoint Surgical Inc.
Paragonix Technologies, Inc.
Lundbeck LLC
Illumina, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.